State Street’s Redhill Biopharma RDHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-52
| Closed | -$45K | – | 4949 |
|
|
2022
Q2 | $45K | Hold |
52
| – | – | ﹤0.01% | 4743 |
|
|
2022
Q1 | $131K | Buy |
52
+3
| +6% | +$7.56K | ﹤0.01% | 4548 |
|
|
2021
Q4 | $127K | Buy |
49
+2
| +4% | +$5.18K | ﹤0.01% | 4519 |
|
|
2021
Q3 | $216K | Sell |
47
-63
| -57% | -$290K | ﹤0.01% | 4329 |
|
|
2021
Q2 | $754K | Buy |
110
+16
| +17% | +$110K | ﹤0.01% | 3720 |
|
|
2021
Q1 | $690K | Sell |
94
-17
| -15% | -$125K | ﹤0.01% | 3690 |
|
|
2020
Q4 | $939K | Buy |
111
+9
| +9% | +$76.1K | ﹤0.01% | 3562 |
|
|
2020
Q3 | $1.04M | Buy |
102
+90
| +750% | +$917K | ﹤0.01% | 3419 |
|
|
2020
Q2 | $80K | Sell |
12
-82
| -87% | -$547K | ﹤0.01% | 3673 |
|
|
2020
Q1 | $426K | Buy |
94
+14
| +18% | +$63.4K | ﹤0.01% | 3475 |
|
|
2019
Q4 | $484K | Buy |
+80
| New | +$484K | ﹤0.01% | 3528 |
|